MEPRIMET M3 TABLET

Product Description

MEPRIMET M3 TABLET is a clinically formulated bilayered tablet combining Glimepiride 3mg and Metformin Hydrochloride 500mg (Sustained Release), designed for optimal management of Type 2 Diabetes Mellitus. This advanced combination therapy effectively controls blood glucose levels by enhancing insulin sensitivity and stimulating insulin secretion.Ideal for medical distributors, pharmaceutical wholesalers, retail pharmacies, and bulk buyers, MEPRIMET M3 offers reliable efficacy, improved patient adherence, and a favorable safety profile. Manufactured adhering to stringent quality standards, it ensures consistent therapeutic outcomes.Key Benefits: Dual-action formulation for superior glycemic control Sustained-release Metformin ensures prolonged efficacy and reduced gastrointestinal side effects Supports improved insulin sensitivity and pancreatic beta-cell function Manufactured under GMP-certified facilities guaranteeing purity and safety Usage: Indicated for the management of Type 2 Diabetes Mellitus Suitable as monotherapy or in combination with other antidiabetic agents Helps in maintaining long-term blood sugar control and reducing diabetic complications Why Choose MEPRIMET M3 TABLET? Trusted formulation preferred by healthcare professionals Competitive pricing for bulk procurement and distribution Available for bulk supply with consistent stock for all pharmaceutical trade requirements